Immix Biopharma (IMMX) Operating Leases (2024 - 2026)
Quarterly results put Operating Leases at $912343.0 for Q1 2026, down 7.95% from a year ago — trailing twelve months through Mar 2026 was $912343.0 (down 7.95% YoY), and the annual figure for FY2025 was $933625.0, down 7.52%.
Immix Biopharma has reported Operating Leases over the past 3 years, most recently at $912343.0 for Q1 2026.
- Operating Leases reached $912343.0 in Q1 2026 per IMMX's latest filing, down from $933625.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.1 million in Q1 2024 and bottomed at $912343.0 in Q1 2026.
- Median Operating Leases over the past 3 years was $991126.0 (2025), compared with a mean of $990235.6.
- The largest annual shift saw Operating Leases decreased 5.97% in 2025 before it dropped 7.95% in 2026.
- Over 3 years, Operating Leases stood at $1.0 million in 2024, then decreased by 7.52% to $933625.0 in 2025, then dropped by 2.28% to $912343.0 in 2026.
- Business Quant data shows Operating Leases for IMMX at $912343.0 in Q1 2026, $933625.0 in Q4 2025, and $965053.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 912,343.00 |
| Dec 31, 2025 | 933,625.00 |
| Sep 30, 2025 | 965,053.00 |
| Jun 30, 2025 | 972,335.00 |
| Mar 31, 2025 | 991,126.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.06 Mn |